[{"address1": "9301 Amberglen Boulevard", "address2": "Suite 100", "city": "Austin", "state": "TX", "zip": "78729", "country": "United States", "phone": "512 869 1555", "website": "https://www.mtem.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of biologic therapeutics for the treatment of cancer and other serious diseases in the United States. The company develops therapies through its proprietary biologic drug platform technology (ETB). It is also developing MT- 8421, an ETB candidate that is in Phase I clinical trial for the treatment of dismantling TME through direct cell-kill of tumor and immune cell; MT-0169, which is in Phase I clinical trial to treat relapsed/refractory multiple myeloma; and MT-6402 in that is in Phase I clinical trial for relapsed/refractory patients with PD-L1 expressing tumors. The company has a collaboration agreement with Bristol Myers Squibb to discover and develop novel products containing ETBs directed to multiple targets. Molecular Templates, Inc. was founded in 2001 and is headquartered in Austin, Texas.", "fullTimeEmployees": 62, "companyOfficers": [{"maxAge": 1, "name": "Dr. Eric E. Poma Ph.D.", "age": 52, "title": "Interim CFO, Treasurer, Principal Acc. Officer, CEO, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 723809, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kristen  Quigley B.A.", "age": 53, "title": "Chief Operating Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Grace  Kim Ph.D.", "title": "Chief Strategy Officer & Head of IR", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michelle  Iwamoto-Fan J.D., Ph.D.", "title": "Senior Vice President & General Counsel", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joseph  Phillips Ph.D.", "title": "Senior VP & Head of CMC Development", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Chris  Moore Ph.D.", "title": "Senior VP and Head of Preclinical Development & Translational Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 7, "shareHolderRightsRisk": 5, "overallRisk": 10, "governanceEpochDate": 1738368000, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.0003, "open": 0.0003, "dayLow": 0.0003, "dayHigh": 0.0003, "regularMarketPreviousClose": 0.0003, "regularMarketOpen": 0.0003, "regularMarketDayLow": 0.0003, "regularMarketDayHigh": 0.0003, "beta": 1.219, "forwardPE": -0.00012765959, "volume": 116, "regularMarketVolume": 116, "averageVolume": 11374907, "averageVolume10days": 12276, "averageDailyVolume10Day": 12276, "bid": 0.0301, "ask": 0.039, "marketCap": 1975, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 4.12, "priceToSalesTrailing12Months": 7.754221e-05, "fiftyDayAverage": 0.1322744, "twoHundredDayAverage": 0.8984236, "currency": "USD", "enterpriseValue": 1371975, "profitMargins": -0.61351, "floatShares": 4519768, "sharesOutstanding": 6583880, "sharesShort": 297946, "sharesShortPriorMonth": 2459220, "sharesShortPreviousMonthDate": 1731628800, "dateShortInterest": 1734048000, "sharesPercentSharesOut": 0.045300003, "heldPercentInsiders": 0.03961, "heldPercentInstitutions": 0.34954, "shortRatio": 0.01, "shortPercentOfFloat": 0.0645, "impliedSharesOutstanding": 6585000, "bookValue": 1.08, "priceToBook": 0.00027777778, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -15626000, "trailingEps": -3.05, "forwardEps": -2.35, "lastSplitFactor": "1:15", "lastSplitDate": 1691971200, "enterpriseToRevenue": 0.054, "enterpriseToEbitda": -0.099, "52WeekChange": -0.99991524, "SandP52WeekChange": 0.21142256, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "MTEM", "underlyingSymbol": "MTEM", "shortName": "Molecular Templates, Inc.", "longName": "Molecular Templates, Inc.", "firstTradeDateEpochUtc": 1107527400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "50b78e85-ce75-3e81-80ea-f799bd42f2e1", "messageBoardId": "finmb_27892633", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0003, "recommendationKey": "none", "totalCash": 9657000, "totalCashPerShare": 1.467, "ebitda": -13865000, "totalDebt": 11027000, "quickRatio": 1.361, "currentRatio": 1.565, "totalRevenue": 25470000, "debtToEquity": 155.07, "revenuePerShare": 4.544, "returnOnAssets": -0.37884, "grossProfits": -3757000, "freeCashflow": -17498624, "operatingCashflow": -23924000, "revenueGrowth": -0.917, "grossMargins": -0.14751, "ebitdaMargins": -0.54437, "operatingMargins": -14.5035, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-02-08"}]